Wayne Holman Ridgeback Capital Investments Medicine ADAP, Adaptimmune, CLLS, ALCLS, Cellectis, FGEN, Fibrogen, MGNX, Macrogenics, AGTC, applied genetic technologies, SGMO, Sangamo, Trillium, TRIL, IRWD, Ironwood, UTHR, United Therapeautics, BMRN, Biomarin, CELG, Celgene, CLDX, Celldex, CMRX, Chi
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 05.02.2021 | Reverie La... | reverielab... | $25M | United Sta... |
| - | Epizyme | epizyme.co... | $496M | United Sta... |
| - | Alder Biop... | alderbio.c... | $38M | - |
| - | FibroGen | fibrogen.c... | - | United Sta... |
| - | Cellectis | cellectis.... | - | United Sta... |
| - | Gilead Sci... | gilead.com | $300M | United Sta... |
| - | Sangamo Th... | sangamo.co... | - | United Sta... |
| - | United The... | unither.co... | - | United Sta... |
| - | Intercept ... | interceptp... | $30M | United Sta... |
| - | MacroGenic... | macrogenic... | - | United Sta... |
Show more
Mentions in press and media 2
| Date | Title | Description | Source |
| 29.11.2021 | Syncona : Quell Therapeutics Raises $156 million in Oversubs... | - Series B co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity ... | marketscre... |
| 29.11.2021 | Quell Therapeutics Raises $156 million in Oversubscribed Ser... | - Series B co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity ... | svhealthin... |